top of page


The results of a Phase 2 trial using a drug strategy pioneered by our director, Richard Smith M.D., in collaboration with Ionis Pharmaceuticals and the University of California, San Diego has been reported to demonstrate promising results in a Biogen-sponsored treatment trial. Click here for more information.

Dr. Richard Smith spoke during the 'Meet the Experts' session at the California 9th ALS Research Summit held at UC Irvine. Click here to see a recording of his presentation.

At the 29th International ALS/MND Symposium in Glasgow, Scotland, Dr. Smith presented on "The Computer Assessment of Speech in a Successful ALS Treatment Trial". The abstract is can be found here.

bottom of page